Johne's disease

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.

NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.

GeneThera is currently negotiating formal licensing agreements with the Universita di Roma "Tor Vegata" and Universita Cattolica del Sacro Cuore, which have jointly developed a potential liposome-based therapeutic for Johne's disease, an uncurable bacterial disease affecting the intestinal tract of livestock.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.